Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects.
Procathepsin D (pCD) is a major secreted protein in estrogen receptor-positive (ER+) breast cancer cell lines. Several independent studies have documented pronounced mitogenic effect of secreted pCD on cancer tissue-derived cell lines, including those from breast, lung, and prostate cancer. It has also been shown that the proliferative effect of pCD involves both autocrine and paracrine modes of action. Recent studies have suggested that pCD could act as a key paracrine communicator between cancer and stromal cells. We have shown earlier that the proliferative activity of pCD depends on the activation peptide sequence of pCD. The present study casts light on the mechanism by which pCD influences the proliferation of cancer cells expressing the ER. Results described in the current paper clearly show that pCD initiates secretion of cytokines interleukin-4 (IL-4), IL-8, IL-10, IL-13, macrophage inflammatory protein-1beta and (MIP-1beta) from such tumor cells. Secreted cytokines take part in the proliferation of the cancer cells, as proven by selective inhibition using antibodies. In addition, expression of cytokine receptors on tested cell lines corresponded to the effects of individual cytokines. An analogous pattern was also observed for fibroblasts, which, under physiologic conditions, are the cells in closest contact with the tumor tissue and play a role in tumor growth and invasion. Our observations were further supported by coculture experiments that are in agreement. Although very similar in response to addition of pCD, the invasive ER- cells do not secrete cytokines. Together with previous in vivo results, these data point to pCD as one of key molecules for therapeutic attack in breast cancer.
Fusek
Martin
M
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 161 00 Prague 6, Czech Republic.
Vetvickova
Jana
J
Vetvicka
Vaclav
V
D000818:Animals; D019898:Autocrine Communication; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D002402:Cathepsin D / Q000378:metabolism* / Q000627:therapeutic use; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D016207:Cytokines / Q000378:metabolism*; D004792:Enzyme Precursors / Q000378:metabolism* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D019899:Paracrine Communication; D011960:Receptors, Estrogen
D016207:Cytokines; D004792:Enzyme Precursors; D011960:Receptors, Estrogen; C058345:procathepsin D; D002402:Cathepsin D